Electrophoresis Global Market Report 2024

The global electrophoresis market has grown strongly in recent years. It will grow from $2.96 billion in 2023 to $3.15 billion in 2024 at a compound annual growth rate (CAGR) of 6.6%. The historical growth can be attributed to the increasing occurrence of genetic disorders, progress in drug discovery and development, extensive protein analysis in proteomics research, expanding applications of clinical diagnostics, and advancements in the field of molecular biology.

The global electrophoresis market is expected to see strong growth in the next few years. It will grow to $4.14 billion in 2028 at a compound annual growth rate (CAGR) of 7.0%. The anticipated growth in the forecast period is fueled by the transition towards capillary electrophoresis, the increasing need for high-throughput analysis, growth in food and beverage testing, diagnostic applications focusing on infectious diseases, and advancements in microfluidic electrophoresis. Major trends expected during this period encompass the adoption of next-generation sequencing (NGS) and omics technologies, the integration of artificial intelligence (AI) in data analysis, the customization and personalization of electrophoresis systems, market expansion within emerging economies, and strategic acquisitions and mergers within the industry.

The surge in cancer, infectious diseases, and genetic disorders is poised to drive the electrophoresis market's growth. Infections with pandemic potential, such as plague, cholera, flu, and severe acute respiratory syndrome, alongside the multifaceted nature of cancer without a single cause, have increased the use of electrophoresis. This method helps in DNA, RNA, or protein molecule detection and separation, aiding in determining antibiotic concentrations for more accurate dosages. According to the EU Science Hub's October 2023 article, new cancer cases rose by 2.3% in 2022 compared to 2020, reaching 2.74 million. Similarly, cancer-related deaths increased by 2.4% in 2022 compared to 2020. Hence, the mounting incidence of cancer and infectious diseases will propel the electrophoresis market's growth.

A surge in research endeavors is anticipated to steer the electrophoresis market's expansion. These research activities encompass organized efforts aimed at gathering, analyzing, and generating new knowledge in specific fields. Electrophoresis serves as a fundamental technique in molecular biology and biochemistry research, enabling the separation and analysis of DNA, RNA, and proteins. It is pivotal in unraveling genetic information, studying protein structures, and investigating molecular interactions, contributing significantly to genetics, genomics, proteomics, and drug discovery. According to the National Center for Science and Engineering Statistics' January 2023 article, U.S. R&D spending surged by $51 billion in 2020, reaching $717 billion, and is estimated to hit $792 billion in 2021. Hence, the upswing in research activities drives the genome editing and genome engineering market.

Technological advancements stand out as a pivotal trend shaping the electrophoresis market. Leading companies in this sector are embracing innovative technological solutions to maintain their positions. For instance, in May 2023, the U.S.-based miniPCR bio, a life sciences company, introduced the GELATO electrophoresis system. This system integrates gel electrophoresis with transillumination technology, enabling nucleic acid separation and visualization within a compact design.

Significant industry players are forging partnerships to fortify their positions in the electrophoresis market. These strategic alliances between commercial enterprises aim to enhance therapeutic protein development by merging mass spectrometry (MS) with essential protein separation techniques. For example, in June 2021, Thermo Fisher Scientific Inc., a U.S.-based biotechnology company, partnered with Advanced Electrophoresis Solutions Ltd., a Canada-based provider of cutting-edge instrumentation and supplies in the iCIEF field.

In July 2021, PerkinElmer, a prominent US-based biotechnology research firm, finalized the acquisition of Biolegend for a substantial $5.25 billion. This acquisition marks a transformative step for PerkinElmer, aimed at bolstering its position in Life Science endeavors, with a focus on propelling significant advancements in precision medicine. Biolegend, headquartered in the US, specializes in the manufacturing of antibodies and reagents crucially employed in biomedical research. The strategic integration of Biolegend into PerkinElmer's portfolio is poised to amplify the company's capabilities and accelerate pioneering discoveries within the realm of precision medicine, further cementing its foothold in the life sciences domain.

Major companies operating in the electrophoresis market report are Bio-Rad Laboratories Inc., Thermo Fisher Scientific Inc., Danaher Corporation, Agilent Technologies Inc., General Electric Company, Merck Group, PerkinElmer Inc., QIAGEN N.V., Lonza Group Limited, Shimadzu Corporation, Harvard Bioscience Inc., C.B.S. Scientific Company Inc., Takara Bio Inc., Sebia Group, Analytik Jena AG, Biochrom Ltd., Biometra GmbH, Cleaver Scientific Ltd., Helena Laboratories Corporation, Hoefer Inc., Labnet International Inc., Major Science Co. Ltd., Prona Technologies Inc., Alfa Wassermann Inc., CompareNetworks Inc., Eppendorf SE, Promega Corporation, Corning Inc., LI-COR Biosciences, F. Hoffmann-La Roche AG

North America was the largest region in the electrophoresis market in 2023. The regions covered in the electrophoresis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the electrophoresis market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The primary products associated with electrophoresis encompass electrophoresis reagents, electrophoresis systems, gel documentation systems, and electrophoresis software. Electrophoresis reagents are formulations tailored to streamline the separation and analysis of samples during electrophoretic procedures. This technique finds applications across research, diagnostics, quality control, and process validation, catering to diverse end-users including academic and research institutions, pharmaceutical and biotechnology firms, hospitals, and other relevant entities.

This report provides electrophoresis market statistics, including electrophoresis industry global market size, regional shares, competitors with an electrophoresis market share, detailed electrophoresis market segments, market trends and opportunities, and any further data you may need to thrive in the electrophoresis industry. This electrophoresis market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The electrophoresis market includes revenues earned by entities by providing capillary electrophoresis, routine electrophoresis, polyacrylamide gel electrophoresis, 2D electrophoresis, pulsed field electrophoresis, isoelectric focusing, and immunochemical electrophoresis. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.